scispace - formally typeset
E

Emily J. Gilmore

Researcher at Yale University

Publications -  109
Citations -  3272

Emily J. Gilmore is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 78 publications receiving 1814 citations. Previous affiliations of Emily J. Gilmore include Comprehensive Epilepsy Center & Columbia University.

Papers
More filters
Journal ArticleDOI

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Michael D. Hill, +776 more
- 14 Mar 2020 - 
TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.
Journal ArticleDOI

American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version.

TL;DR: In the early 2000s, a subcommittee of the American Clinical Neurophysiology Society (ACNS) set out to standardize terminology of periodic and rhythmic EEG patterns in the critically ill to aid in future research involving such patterns as mentioned in this paper.
Journal ArticleDOI

Prognostication of post-cardiac arrest coma: early clinical and electroencephalographic predictors of outcome

TL;DR: Non-ventricular fibrillation/tachycardia arrest, longer time to ROSC, absence of brainstem reflexes, extensor or no motor response, lower pH, higher lactate, hypotension requiring >2 vasopressors, and absence of reactivity on EEG were all associated with poor outcome.
Journal ArticleDOI

Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients.

TL;DR: LPDs, LRDA, and GPDs were associated with seizures while generalized rhythmic delta activity was not and the importance of detailed electroencephalographic interpretation using standardized nomenclature for seizure risk stratification and clinical decision making is highlighted.